Matrix Degrading Metalloproteinases

Overview

Journal J Neurooncol

Publisher Springer

Date 1993 Jan 1

PMID 7964973

Citations 15

Authors

B W Ennis

L M Matrisian

Affiliations

Soon will be listed here.

Abstract

Matrix degrading metalloproteinases are enzymes that degrade proteins in tissue extracellular matrices. These proteinases exhibit specific, well defined properties that allow them to be classified into a family of enzymes. They are secreted by various cell types as the cells effect their surrounding extracellular matrix. Such effects occur during normal physiologic tissue remodeling but also during pathologic processes such as tumor cell invasion and metastases. Currently there are seven proteases classified as members of the matrix metalloproteinase family and there are two putative members. Direct correlations can be made between the matrix metalloproteinases and normal tissue functions such as bone remodeling, uterine and mammary gland function and ovulation. The matrix metalloproteinases are also strongly associated with cancer progression in that they function to degrade epithelial basement membrane and stromal matrices in many different malignancies including brain tumors.

Citing Articles

Connecting secretome to hematopoietic stem cell phenotype shifts in an engineered bone marrow niche.

Gilchrist A, Harley B Integr Biol (Camb). 2020; 12(7):175-187.

PMID: 32556172 PMC: 7384206. DOI: 10.1093/intbio/zyaa013.

The Trinity of Matrix Metalloproteinases, Inflammation, and Cancer: A Literature Review of Recent Updates.

Ozkan E, Bakar-Ates F Antiinflamm Antiallergy Agents Med Chem. 2020; 19(3):206-221.

PMID: 32178620 PMC: 7499348. DOI: 10.2174/1871523018666191023141807.

Engineering a highly elastic human protein-based sealant for surgical applications.

Annabi N, Zhang Y, Assmann A, Sani E, Cheng G, Lassaletta A Sci Transl Med. 2017; 9(410).

PMID: 28978753 PMC: 11186511. DOI: 10.1126/scitranslmed.aai7466.

Pair-wise comparison analysis of differential expression of mRNAs in early and advanced stage primary colorectal adenocarcinomas.

Lau T, Roslani A, Lian L, Chai H, Lee P, Hilmi I BMJ Open. 2014; 4(8):e004930.

PMID: 25107436 PMC: 4127931. DOI: 10.1136/bmjopen-2014-004930.

Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI.

Harris R, Bookheimer S, Cloughesy T, Kim H, Pope W, Lai A J Neurooncol. 2013; 116(2):373-9.

PMID: 24234804 PMC: 6763342. DOI: 10.1007/s11060-013-1304-2.

References

Rao J, Steck P, Mohanam S, Stetler-Stevenson W, Liotta L, Sawaya R . Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res. 1993; 53(10 Suppl):2208-11. View

Colton C, Keri J, Chen W, Monsky W . Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation. J Neurosci Res. 1993; 35(3):297-304. DOI: 10.1002/jnr.490350309. View

De Clerck Y, Yean T, Ratzkin B, Lu H, Langley K . Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem. 1989; 264(29):17445-53. View

Alexander C, Werb Z . Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. J Cell Biol. 1992; 118(3):727-39. PMC: 2289547. DOI: 10.1083/jcb.118.3.727. View

Talhouk R, Chin J, Unemori E, Werb Z, Bissell M . Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development. 1991; 112(2):439-49. PMC: 2975574. DOI: 10.1242/dev.112.2.439. View

Denbesten P, Heffernan L, Treadwell B, Awbrey B . The presence and possible functions of the matrix metalloproteinase collagenase activator protein in developing enamel matrix. Biochem J. 1989; 264(3):917-20. PMC: 1133672. DOI: 10.1042/bj2640917. View

Woessner Jr J, Taplin C . Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem. 1988; 263(32):16918-25. View

Shapiro S, Griffin G, Gilbert D, Jenkins N, Copeland N, Welgus H . Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem. 1992; 267(7):4664-71. View

Miyazaki K, Funahashi K, Numata Y, Koshikawa N, Akaogi K, Kikkawa Y . Purification and characterization of a two-chain form of tissue inhibitor of metalloproteinases (TIMP) type 2 and a low molecular weight TIMP-like protein. J Biol Chem. 1993; 268(19):14387-93. View

10.

Nakano A, Tani E, Miyazaki K, Furuyama J, Matsumoto T . Expressions of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Commun. 1993; 192(3):999-1003. DOI: 10.1006/bbrc.1993.1515. View

11.

Librach C, Werb Z, Fitzgerald M, Chiu K, Corwin N, Esteves R . 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol. 1991; 113(2):437-49. PMC: 2288933. DOI: 10.1083/jcb.113.2.437. View

12.

Senior R, Griffin G, Fliszar C, Shapiro S, Goldberg G, Welgus H . Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem. 1991; 266(12):7870-5. View

13.

DeClerck Y, Yean T, Lu H, Ting J, Langley K . Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J Biol Chem. 1991; 266(6):3893-9. View

14.

Lefebvre O, Wolf C, Limacher J, Hutin P, Wendling C, Lemeur M . The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J Cell Biol. 1992; 119(4):997-1002. PMC: 2289688. DOI: 10.1083/jcb.119.4.997. View

15.

Liotta L, Steeg P, Stetler-Stevenson W . Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991; 64(2):327-36. DOI: 10.1016/0092-8674(91)90642-c. View

16.

Matrisian L, Bowden G, Krieg P, Furstenberger G, Briand J, Leroy P . The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci U S A. 1986; 83(24):9413-7. PMC: 387148. DOI: 10.1073/pnas.83.24.9413. View

17.

Nagase H, Ogata Y, Suzuki K, Enghild J, Salvesen G . Substrate specificities and activation mechanisms of matrix metalloproteinases. Biochem Soc Trans. 1991; 19(3):715-8. DOI: 10.1042/bst0190715. View

18.

Matrisian L . Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990; 6(4):121-5. DOI: 10.1016/0168-9525(90)90126-q. View

19.

Martelli M, Campana A, Bischof P . Secretion of matrix metalloproteinases by human endometrial cells in vitro. J Reprod Fertil. 1993; 98(1):67-76. DOI: 10.1530/jrf.0.0980067. View

20.

Khokha R, Waterhouse P, Yagel S, Lala P, Overall C, Norton G . Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science. 1989; 243(4893):947-50. DOI: 10.1126/science.2465572. View